Guillermo Novo - Nov 17, 2025 Form 4 Insider Report for ASHLAND INC. (ASH)

Signature
/s/ Serena S. Kenost, Attorney-in-fact for Guillermo Novo
Stock symbol
ASH
Transactions as of
Nov 17, 2025
Transactions value $
$176,526
Form type
4
Date filed
11/19/2025, 04:30 PM
Previous filing
Nov 17, 2025
Next filing
Nov 21, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
NOVO GUILLERMO Chair of the Board and CEO, Director 8145 BLAZER DRIVE, WILMINGTON /s/ Serena S. Kenost, Attorney-in-fact for Guillermo Novo 2025-11-19 0001434813

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASH Common Stock Options Exercise $304K +6.12K +4.46% $49.60 143K Nov 17, 2025 Direct
transaction ASH Common Stock Tax liability -$127K -2.56K -1.79% $49.60 141K Nov 17, 2025 Direct F1
holding ASH Common Stock 31.3K Nov 17, 2025 By GMGN Novo Family Limited Partnershi

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASH Restricted Stock Unit Options Exercise $0 -6.12K -100% $0.00 0 Nov 17, 2025 Common Stock 6.12K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Payment of a tax liability by withholding securities incident to the vesting of Restricted Stock Units acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3.
F2 Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland common stock upon vesting.
F3 Grant of Restricted Stock Units pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant vest in three equal installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer.